Isoforms of human leukocyte antigen-G and their inhibitory receptors in human kidney allograft acceptance

Human Immunology

Volumn 70, Issue 12, 2009, Pages 988-994

  Wu, Juan ^a   Zhang, Wei ^a   Hernandez Lopez, Pedro ^a   Fabelo, Edward ^a   Parikh, Mehul ^a   Mulloy, Laura L ^a   Horuzsko, Anatolij ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Dendritic cells; Inhibitory receptors; Kidney allograft; T cells; Tolerance; Transplantation

Indexed keywords

CD11B ANTIGEN; DIMER; DISULFIDE BONDED DIMER; HLA ANTIGEN CLASS 1; HLA G ANTIGEN; HLA G1 ANTIGEN; HLA G5 ANTIGEN; IMMUNOGLOBULIN LIKE TRANSCRIPT 2 RECEPTOR; IMMUNOGLOBULIN LIKE TRANSCRIPT 4 RECEPTOR; IMMUNOGLOBULIN RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL4; MONOMER; NATURAL KILLER CELL RECEPTOR; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CELL EXPANSION; DENDRITIC CELL; DIMERIZATION; GRAFT SURVIVAL; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; KIDNEY ALLOGRAFT; KIDNEY ALLOGRAFT REJECTION; MAJOR HISTOCOMPATIBILITY COMPLEX; MYELOID DERIVED SUPPRESSOR CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STOP CODON; STRUCTURAL GENOMICS; SUPPRESSOR CELL; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD; DENDRITIC CELLS; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; KIDNEY TRANSPLANTATION; MEMBRANE GLYCOPROTEINS; MICE; MICE, TRANSGENIC; PROTEIN ISOFORMS; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS;

EID: 70350738359     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2009.07.023     Document Type: Article

References (62)

1. Kean L.S., Gangappa S., Pearson T.C., and Larsen C.P. Transplant tolerance in non-human primates: progress, current challenges and unmet needs. Am J Transplant 6 (2006) 884-893
2. Calne R.Y. Transplantation: current developments and future directions. Frontiers Biosci 12 (2007) 3727-3733
3. Newell K.A., and Larsen C.P. Transplantation tolerance. Semin Nephrol 27 (2007) 487-497
4. Kirk A.D. Clinical tolerance 2008. Transplantation 87 (2009) 953-955
5. Sykes M. Mechanisms of transplantation tolerance in animals and humans. Transplantation 87 (2009) S67-S69
6. Hunt J.S. Stranger in a strange land. Immunol Rev 213 (2006) 36-47
7. Carosella E.D., Moreau P., Lemaoult J., and Rouas-Freiss N. HLA-G: from biology to clinical benefits. Trends Immunol 29 (2008) 125-132
8. Carosella E.D., Favier B., Rouas-Freiss N., Moreau P., and Lemaoult J. Beyond the increasing complexity of the immunomodulatory HLA-G molecule. Blood 111 (2008) 4862-4870
9. Riley J.K., and Yokoyama W.M. NK cell tolerance and the maternal-fetal interface. Am J Reprod Immunol 59 (2008) 371-387
10. Ristich V., Liang S., Zhang W., Wu J., and Horuzsko A. Tolerization of dendritic cells by HLA-G. Eur J Immunol 35 (2005) 1133-1142
11. Liang S., Zhang W., and Horuzsko A. Human ILT2 receptor associates with murine MHC class I molecules in vivo and impairs T cell function. Eur J Immunol 36 (2006) 2457-2471
12. Ristich V., Zhang W., Liang S., and Horuzsko A. Mechanisms of prolongation of allograft survival by HLA-G/ILT4-modified dendritic cells. Hum Immunol 68 (2007) 264-271
13. Qiu J., Terasaki P.I., Miller J., Mizutani K., Cai J., and Carosella E.D. Soluble HLA-G expression and renal graft acceptance. Am J Transplant 6 (2006) 2152-2156
14. Liang S., Ristich V., Arase H., Dausset J., Carosella E.D., and Horuzsko A. Modulation of dendritic cell differentiation by HLA-G and ILT4 requires the IL-6-STAT3 signaling pathway. Proc Natl Acad Sci USA 105 (2008) 8357-8362
15. Rouas-Freiss N., Naji A., Durrbach A., and Carosella E.D. Tolerogenic functions of human leukocyte antigen G: from pregnancy to organ and cell transplantation. Transplantation 84 (2007) S21-S25
16. + myeloid-derived suppressor cells that promote long-term survival of allografts. Transplantation 86 (2008) 1125-1134
17. Hunt J.S., Petroff M.G., McIntire R.H., and Ober C. HLA-G and immune tolerance in pregnancy. Faseb J 19 (2005) 681-693
18. Park B., Lee S., Kim E., Chang S., Jin M., and Ahn K. The truncated cytoplasmic tail of HLA-G serves a quality-control function in post-ER compartments. Immunity 15 (2001) 213-224
19. Colonna M., Navarro F., Bellon T., Llano M., Garcia P., Samaridis J., et al. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med 186 (1997) 1809-1818
20. Cosman D., Fanger N., Borges L., Kubin M., Chin W., Peterson L., et al. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 7 (1997) 273-282
21. Brown D., Trowsdale J., and Allen R. The LILR family: modulators of innate and adaptive immune pathways in health and disease. Tissue Antigens 64 (2004) 215-225
22. LeMaoult J., Zafaranloo K., Le Danff C., and Carosella E.D. HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells. Faseb J 19 (2005) 662-664
23. Pazmany L., Mandelboim O., Vales-Gomez M., Davis D.M., Reyburn H.T., and Strominger J.L. Protection from natural killer cell-mediated lysis by HLA-G expression on target cells. Science 274 (1996) 792-795
24. Munz C., Holmes N., King A., Loke Y.W., Colonna M., Schild H., et al. Human histocompatibility leukocyte antigen (HLA)-G molecules inhibit NKAT3 expressing natural killer cells. J Exp Med 185 (1997) 385-391
25. Pende D., Sivori S., Accame L., Pareti L., Falco M., Geraghty D., et al. HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex. Eur J Immunol 27 (1997) 1875-1880
26. Soderstrom K., Corliss B., Lanier L.L., and Phillips J.H. CD94/NKG2 is the predominant inhibitory receptor involved in recognition of HLA-G by decidual and peripheral blood NK cells. J Immunol 159 (1997) 1072-1075
27. Mandelboim O., Pazmany L., Davis D.M., Vales-Gomez M., Reyburn H.T., Rybalov B., et al. Multiple receptors for HLA-G on human natural killer cells. Proc Natl Acad Sci USA 94 (1997) 14666-14670
28. Rajagopalan S., and Long E.O. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells. J Exp Med 189 (1999) 1093-1100
29. Ponte M., Cantoni C., Biassoni R., Tradori-Cappai A., Bentivoglio G., Vitale C., et al. Inhibitory receptors sensing HLA-G1 molecules in pregnancy: decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor. Proc Natl Acad Sci USA 96 (1999) 5674-5679
30. Boyson J.E., Erskine R., Whitman M.C., Chiu M., Lau J.M., Koopman L.A., et al. Disulfide bond-mediated dimerization of HLA-G on the cell surface. Proc Natl Acad Sci USA 99 (2002) 16180-16185
31. Apps R., Gardner L., Sharkey A., Trundley A., and Moffett A. HLA-G is present on the surface of normal extravillous trophoblast as homodimers with high avidity for the LILR receptors of decidual leukocytes. Tissue Antigens 68 (2006) 359
32. Gonen-Gross T., Achdout H., Gazit R., Hanna J., Mizrahi S., Markel G., et al. Complexes of HLA-G protein on the cell surface are important for leukocyte Ig-like receptor-1 function. J Immunol 171 (2003) 1343-1351
33. Shiroishi M., Kuroki K., Rasubala L., Tsumoto K., Kumagai I., Kurimoto E., et al. Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d). Proc Natl Acad Sci USA 103 (2006) 16412-16417
34. Chang C.C., Ciubotariu R., Manavalan J.S., Yuan J., Colovai A.I., Piazza F., et al. Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat Immunol 3 (2002) 237-243
35. + tolerogenic endothelial cells, inhibiting alloreactivity. Int Immunol 16 (2004) 1055-1068
36. + T suppressor cells mediate tolerance to allogeneic heart transplants, inducing PIR-B in APC and rendering the graft invulnerable to rejection. Transpl Immunol 13 (2004) 239-247
37. Suciu-Foca N., Manavalan J.S., Scotto L., Kim-Schulze S., Galluzzo S., Naiyer A.J., et al. Molecular characterization of allospecific T suppressor and tolerogenic dendritic cells: review. Int Immunopharmacol 5 (2005) 7-11
38. + T suppressor cells. J Immunol 176 (2006) 2790-2798
39. Buckland M., Jago C.B., Fazekasova H., Scott K., Tan P.H., George A.J., et al. Aspirin-treated human DCs up-regulate ILT-3 and induce hyporesponsiveness and regulatory activity in responder T cells. Am J Transplant 6 (2006) 2046-2059
40. Wu J., and Horuzsko A. Expression and function of immunoglobulin-like transcripts on tolerogenic dendritic cells. Hum Immunol 70 (2009) 353-356
41. Lefebvre S., Antoine M., Uzan S., McMaster M., Dausset J., Carosella E.D., et al. Specific activation of the non-classical class I histocompatibility HLA-G antigen and expression of the ILT2 inhibitory receptor in human breast cancer. J Pathol 196 (2002) 266-274
42. Wiendl H., Mitsdoerffer M., Hofmeister V., Wischhusen J., Weiss E.H., Dichgans J., et al. The non-classical MHC molecule HLA-G protects human muscle cells from immune-mediated lysis: implications for myoblast transplantation and gene therapy. Brain 126 (2003) 176-185
43. Fainardi E., Rizzo R., Melchiorri L., Vaghi L., Castellazzi M., Marzola A., et al. Presence of detectable levels of soluble HLA-G molecules in CSF of relapsing-remitting multiple sclerosis: relationship with CSF soluble HLA-I and IL-10 concentrations and MRI findings. J Neuroimmunol 142 (2003) 149-158
44. Carosella E.D., Moreau P., Le Maoult J., Le Discorde M., Dausset J., and Rouas-Freiss N. HLA-G molecules: from maternal-fetal tolerance to tissue acceptance. Adv Immunol 81 (2003) 199-252
45. Barrier B.F., Kendall B.S., Ryan C.E., and Sharpe-Timms K.L. HLA-G is expressed by the glandular epithelium of peritoneal endometriosis but not in eutopic endometrium. Hum Reprod 21 (2006) 864-869
46. Torres M.I., Lopez-Casado M.A., Luque J., Pena J., and Rios A. New advances in coeliac disease: serum and intestinal expression of HLA-G. Int Immunol 18 (2006) 713-718
47. Bronte V., Serafini P., De Santo C., Marigo I., Tosello V., Mazzoni A., et al. IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice. J Immunol 170 (2003) 270-278
48. Sinha P., Clements V.K., and Ostrand-Rosenberg S. Interleukin-13-regulated M2 macrophages in combination with myeloid suppressor cells block immune surveillance against metastasis. Cancer Res 65 (2005) 11743-11751
49. Frey A.B. Myeloid suppressor cells regulate the adaptive immune response to cancer. J Clin Invest 116 (2006) 2587-2590
50. + myeloid suppressor cells cause T cell dysfunction after traumatic stress. J Immunol 176 (2006) 2085-2094
51. + T cells. J Clin Invest 116 (2006) 2777-2790
52. Gonen-Gross T., Achdout H., Arnon T.I., Gazit R., Stern N., Horejsi V., et al. The CD85J/leukocyte inhibitory receptor-1 distinguishes between conformed and beta 2-microglobulin-free HLA-G molecules. J Immunol 175 (2005) 4866-4874
53. Shiroishi M., Kuroki K., Ose T., Rasubala L., Shiratori I., Arase H., et al. Efficient leukocyte Ig-like receptor signaling and crystal structure of disulfide-linked HLA-G dimer. J Biol Chem 281 (2006) 10439-10447
54. Feger U., Tolosa E., Huang Y.H., Waschbisch A., Biedermann T., Melms A., et al. HLA-G expression defines a novel regulatory T-cell subset present in human peripheral blood and sites of inflammation. Blood 110 (2007) 568-577
55. Lila N., Amrein C., Guillemain R., Chevalier P., Latremouille C., Fabiani J.N., et al. Human leukocyte antigen-G expression after heart transplantation is associated with a reduced incidence of rejection. Circulation 105 (2002) 1949-1954
56. Creput C., Durrbach A., Menier C., Guettier C., Samuel D., Dausset J., et al. Human leukocyte antigen-G (HLA-G) expression in biliary epithelial cells is associated with allograft acceptance in liver-kidney transplantation. J Hepatol 39 (2003) 587-594
57. + T cells express the immunotolerant HLA-G molecule in mixed lymphocyte reactions: in vivo implications in transplanted patients. Eur J Immunol 34 (2004) 649-660
58. Le Rond S., Azema C., Krawice-Radanne I., Durrbach A., Guettier C., Carosella E.D., et al. Evidence to support the role of HLA-G5 in allograft acceptance through induction of immunosuppressive/ regulatory T cells. J Immunol 176 (2006) 3266-3276
59. Luque J., Torres M.I., Aumente M.D., Marin J., Garcia-Jurado G., Gonzalez R., et al. Soluble HLA-G in heart transplantation: their relationship to rejection episodes and immunosuppressive therapy. Hum Immunol 67 (2006) 257-263
60. Terasaki P.I., and Cai J. Humoral theory of transplantation: further evidence. Curr Opin Immunol 17 (2005) 541-545
61. Rebmann V., Lemaoult J., Rouas-Freiss N., Carosella E.D., and Grosse-Wilde H. Report of the Wet Workshop for Quantification of Soluble HLA-G in Essen, 2004. Hum Immunol 66 (2005) 853-863
62. Kuroki K., Tsuchiya N., Shiroishi M., Rasubala L., Yamashita Y., Matsuta K., et al. Extensive polymorphisms of LILRB1 (ILT2, LIR1) and their association with HLA-DRB1 shared epitope negative rheumatoid arthritis. Hum Mol Genet 14 (2005) 2469-2480